Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

55.49
Delayed Data
As of 4:02pm ET
 -0.58 / -1.03%
Today’s Change
49.03
Today|||52-Week Range
77.12
-5.05%
Year-to-Date
Boulegeris Investments, Inc. Buys Nimble Storage Inc, JPMorgan Chase & Co, Bristol-My...
12:40pm / GuruFocus News - Paid Partner Content
Trump Attacks Biotech & Pharma: ETFs Bleed
Jan 12 / Zacks.com - Paid Partner Content
Oakbrook Investments Llc Buys Visa Inc, Varian Medical Systems Inc, United Technologi...
11:39am / GuruFocus News - Paid Partner Content
3 Charts Every Bristol-Myers Squibb Shareholder Needs to See
Jan 11 / MotleyFool.com - Paid Partner Content
Bristol-Myers (BMY) Q4 Earnings: Will the Stock Disappoint?
9:21am / Zacks.com - Paid Partner Content
Roche Gets Priority Review for Immunotherapy Drug Tecentriq
Jan 10 / Zacks.com - Paid Partner Content
Jacobs & Co Buys Praxair Inc, Procter & Gamble Co, Bristol-Myers Squibb Company, Sell...
Jan 18 / GuruFocus News - Paid Partner Content
Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study
Jan 09 / Zacks.com - Paid Partner Content
Eastern Bank Buys iShares TIPS Bond, Bristol-Myers Squibb Company, iShares Russell Mi...
Jan 18 / GuruFocus News - Paid Partner Content
2 Top Stocks in Biotech
Jan 09 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and B...
Jan 18 / Zacks.com - Paid Partner Content
Here's a Biotech IPO You'll Want to Watch
Jan 09 / MotleyFool.com - Paid Partner Content
AstraZeneca Offers Update on Immuno-Oncology Program
Jan 18 / Zacks.com - Paid Partner Content
5 Tough Questions for Bristol-Myers Squibb's CEO
Jan 07 / MotleyFool.com - Paid Partner Content
Top Research Reports for Microsoft, Biogen & Home Depot
Jan 17 / Zacks.com - Paid Partner Content
It Was CheckMate for Bristol-Myers Squibb Company in 2016
Jan 06 / MotleyFool.com - Paid Partner Content
Why Bristol-Myers Squibb May Be a Merger Target Soon
Jan 17 / TheStreet.com - Paid Partner Content
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
Jan 06 / MotleyFool.com - Paid Partner Content
AstraZeneca expands trials for key cancer drug
Jan 17 / FT.com - Paid Partner Content
Bristol-Myers, J&J Ink Immunotherapy Research Collaboration
Jan 06 / Zacks.com - Paid Partner Content
P.R. Herzig & Co. Inc. Buys Kansas City Southern, Bristol-Myers Squibb Company, Gener...
Jan 13 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 V...
Jan 06 / Zacks.com - Paid Partner Content
P.R. Herzig & Co. Inc. Buys Kansas City Southern, Bristol-Myers Squibb Company, Gener...
Jan 13 / GuruFocus News - Paid Partner Content
Trump threat fails to halt drug price hikes in 2017
Jan 04 / CNNMoney.com
ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk
Jan 13 / Zacks.com - Paid Partner Content
Corporate moments to look out for in 2017
Dec 30 / FT.com - Paid Partner Content
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content